Do regulatory agencies accept steady-state equivalence studies? [Design Issues]

posted by libaiyi – China, 2024-12-04 09:34 (560 d 09:22 ago) – Posting: # 24307
Views: 9,308

Dear friend,

I am currently conducting a single-dose bioequivalence study, but it is difficult to achieve equivalence due to high variability. I am wondering if it is possible to design a steady-state bioequivalence study, but I don't know if regulatory agencies accept steady-state BE studies like this, if there have been successful precedents for such a design, and what the conditions for its application are. Many thanks.


Libaiyi

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
159 visitors (0 registered, 159 guests [including 12 identified bots]).
Forum time: 19:56 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5